Physician profile
Wei He
NPI 1437492451
$11,061.24
in general payments reported to CMS, 2019-2025
59 companies · $3,532 in 2025
The $3,532 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,360 · 2023: $3,648 · 2024: $2,521 · 2025: $3,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,700.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,354.53 | 2023-2025 | Briviact, Fintepla, Nayzilam |
| Abbvie INC. | $886.06 | 2022-2025 | |
| Pfizer INC. | $856.02 | 2022-2025 | |
| Sk Life Science, INC. | $767.36 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $623.44 | 2022-2025 | |
| Emd Serono, INC. | $531.55 | 2022-2025 | Mavenclad |
| Takeda Pharmaceuticals U.S.A., INC. | $516.29 | 2022-2025 | Hyqvia, Gammagard |
| Eisai INC. | $501.89 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $412.57 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lilly USA, LLC | $387.51 | 2023-2025 | Amyvid, Emgality, Kisunla |
| Otsuka America Pharmaceutical, INC. | $304.28 | 2023-2025 | Rexulti, Nuedexta |
| Acadia Pharmaceuticals INC | $273.74 | 2022-2025 | Nuplazid |
| Biogen, INC. | $246.79 | 2022-2025 | Vumerity, Plegridy, Tysabri |
| Argenx US, INC. | $215.30 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Alexion Pharmaceuticals, INC. | $213.27 | 2023-2024 | Ultomiris |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $208.89 | 2022-2025 | |
| Abbott Laboratories | $208.45 | 2022-2023 | Infinity |
| Sumitomo Pharma America, INC. | $203.04 | 2023-2024 | Aptiom |
| Idorsia Pharmaceuticals US INC | $185.85 | 2022-2024 | Quviviq |
| Neurocrine Biosciences, INC. | $185.05 | 2023-2024 | Ingrezza, Ongentys |
| Genentech USA, INC. | $172.77 | 2022-2024 | Ocrevus |
| Neurelis, INC. | $143.88 | 2022-2024 | Valtoco |
| Zoll Respicardia, INC. | $135.46 | 2023 | Remede System |
| Lundbeck LLC | $128.99 | 2023-2024 | Rexulti, Vyepti |
| Tg Therapeutics, INC. | $112.20 | 2025 | |
| Axsome Therapeutics, INC. | $104.22 | 2022-2025 | Sunosi, Symbravo |
| Octapharma USA, INC. | $82.87 | 2022 | |
| Celgene Corporation | $74.65 | 2023-2024 | Zeposia |
| Grifols USA, LLC | $70.32 | 2023-2024 | Gamunex-C |
| Ani Pharmaceuticals, INC. | $63.67 | 2022-2023 | Purified Cortrophin Gel |
| Aucta Pharmaceuticals, INC. | $62.47 | 2024-2025 | Motpoly Xr |
| Avion Pharmaceuticals | $57.30 | 2022-2023 | Dhivy |
| Boston Scientific Corporation | $55.63 | 2023-2025 | General - Pain Management, Vercise |
| Amneal Pharmaceuticals LLC | $53.12 | 2022-2023 | Rytary |
| Biohaven Pharmaceutical Holding Company LTD. | $48.28 | 2022 | |
| Impel Pharmaceuticals LLC | $45.70 | 2025 | Trudhesa |
| Livanova USA, INC. | $39.74 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Amgen INC. | $39.39 | 2022-2023 | Aimovig |
| Medtronic, INC. | $38.31 | 2023 | Activa PC |
| Astrazeneca Pharmaceuticals LP | $36.45 | 2022-2023 | Andexxa |
| Janssen Pharmaceuticals, INC | $35.43 | 2022 | |
| Corium, LLC | $34.83 | 2022-2023 | Adlarity |
| Averitas Pharma INC. | $31.99 | 2025 | Qutenza |
| Sunovion Pharmaceuticals INC. | $27.85 | 2022 | |
| Janssen Biotech, INC. | $25.49 | 2025 | |
| Harmony Biosciences LLC | $23.77 | 2023 | Wakix |
| Insightec,INC | $21.98 | 2023-2024 | Exablate |
| Azurity Pharmaceuticals, INC. | $20.83 | 2024 | Horizant |
| Spr Therapeutics, INC | $20.25 | 2025 | Sprint Pns System |
| Biotronik Nro, INC. | $19.86 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $19.86 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.05 | 2025 | |
| Tersera Therapeutics LLC | $19.05 | 2025 | Prialt |
| Impel Pharmaceuticals INC. | $18.17 | 2023 | Trudhesa |
| Aprecia Pharmaceuticals, LLC | $15.91 | 2023 | Spritam |
| Vanda Pharmaceuticals INC. | $15.25 | 2025 | Ponvory |
| Avanir Pharmaceuticals, INC. | $15.08 | 2022 | |
| Upsher-Smith Laboratories LLC | $14.95 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.34 | 2025 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.